(Q34184890)

31 July 2017

1 reference

title

Genetically manipulated bacterial toxin as a new generation mucosal adjuvant (English)

1 reference

31 July 2017

Yamamoto M

1

1 reference

31 July 2017

McGhee JR

2

1 reference

31 July 2017

Hagiwara Y

3

1 reference

31 July 2017

Otake S

4

1 reference

31 July 2017

Kiyono H

5

1 reference

31 July 2017

publication date

1 March 2001

1 reference

Scandinavian Journal of Immunology

31 July 2017

published in

1 reference

31 July 2017

volume

53

1 reference

31 July 2017

issue

3

1 reference

31 July 2017

page(s)

211-217

1 reference

Lymphocyte homing and homeostasis

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00883.X

The mucosal immune system: from fundamental concepts to vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00883.X

Acute undifferentiated human diarrhea in the tropics. I. Alterations in intestinal micrflora

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00883.X

An investigation of traveller's diarrhoea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00883.X

Cholera toxin genes: nucleotide sequence, deletion analysis and vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00883.X

Amino acid sequence homology between cholera toxin and Escherichia coli heat-labile toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00883.X

Crystal structure of a cholera toxin-related heat-labile enterotoxin from E. coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00883.X

Intestinal electrolyte transport and diarrheal disease (1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00883.X

Mechanisms for mucosal immunogenicity and adjuvancy of Escherichia coli labile enterotoxin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00883.X

Adjuvant activity of Escherichia coli heat-labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00883.X

Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00883.X

Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00883.X

A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00883.X

Cholera holotoxin and its B subunit enhance Peyer's patch B cell responses induced by orally administered influenza virus: disproportionate cholera toxin enhancement of the IgA B cell response

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00883.X

Intestinal mucosal memory and presence of memory cells in lamina propria and Peyer's patches in mice 2 years after oral immunization with cholera toxin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00883.X

The adjuvant action of cholera toxin is associated with an increased intestinal permeability for luminal antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00883.X

Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00883.X

LT(R192G), a non-toxic mutant of the heat-labile enterotoxin of Escherichia coli, elicits enhanced humoral and cellular immune responses associated with protection against lethal oral challenge with Salmonella spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00883.X

Adjuvant activity of the heat-labile enterotoxin from enterotoxigenic Escherichia coli for oral administration of inactivated influenza virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00883.X

Killed Campylobacter elicits immune response and protection when administered with an oral adjuvant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00883.X

Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00883.X

CD28/B7 system of T cell costimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00883.X

B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00883.X

Cholera toxin discriminates between T helper 1 and 2 cells in T cell receptor-mediated activation: role of cAMP in T cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00883.X

Mutants in the ADP-ribosyltransferase cleft of cholera toxin lack diarrheagenicity but retain adjuvanticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00883.X

Mucosal adjuvanticity and immunogenicity of LTR72, a novel mutant of Escherichia coli heat-labile enterotoxin with partial knockout of ADP-ribosyltransferase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00883.X

Mucosal immunogenicity of genetically detoxified derivatives of heat labile toxin from Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00883.X

A genetically detoxified derivative of heat-labile Escherichia coli enterotoxin induces neutralizing antibodies against the A subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3083.2001.00883.X

10.1046/J.1365-3083.2001.00883.X

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference